NLRP3 and Hyperglycemia: Hyperglycemia induces the oxidative reaction and releases ROS, as well as activating the subsequent NLRP3 inflammasome signaling, resulting in injury of podocytes or tubular cells and mesangial cell proliferation, leading to the occurrence and development of DN [3].